KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Long-Term Deferred Tax: 2019-2025

Historic Long-Term Deferred Tax for Xenon Pharmaceuticals (XENE) over the last 7 years, with Sep 2025 value amounting to $11.8 million.

  • Xenon Pharmaceuticals' Long-Term Deferred Tax rose 1014.80% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year increase of 1014.80%. This contributed to the annual value of $9.7 million for FY2024, which is 1105.24% up from last year.
  • Xenon Pharmaceuticals' Long-Term Deferred Tax amounted to $11.8 million in Q3 2025, which was up 6.34% from $11.0 million recorded in Q2 2025.
  • Over the past 5 years, Xenon Pharmaceuticals' Long-Term Deferred Tax peaked at $11.8 million during Q3 2025, and registered a low of $207,000 during Q1 2022.
  • In the last 3 years, Xenon Pharmaceuticals' Long-Term Deferred Tax had a median value of $802,000 in 2023 and averaged $4.3 million.
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Long-Term Deferred Tax plummeted by 59.73% in 2022, and later soared by 2,619.75% in 2025.
  • Quarterly analysis of 5 years shows Xenon Pharmaceuticals' Long-Term Deferred Tax stood at $465,000 in 2021, then climbed by 9.46% to $509,000 in 2022, then surged by 57.56% to $802,000 in 2023, then surged by 1,105.24% to $9.7 million in 2024, then skyrocketed by 1,014.80% to $11.8 million in 2025.
  • Its Long-Term Deferred Tax stands at $11.8 million for Q3 2025, versus $11.0 million for Q2 2025 and $10.9 million for Q1 2025.